DR ANTHONY MELVIN CRASTO,WorldDrugTracker, helping millions, A 90 % paralysed man in action for you, I am suffering from transverse mylitis and bound to a wheel chair,With death on the horizon, This will not stop me, Gods call only..........
DR ANTHONY MELVIN CRASTO Ph.D ( ICT, Mumbai) , INDIA 29Yrs Exp. in the feld of Organic Chemistry,Working for GLENMARK PHARMA at Navi Mumbai, INDIA. Serving chemists around the world. Helping them with websites on Chemistry.Million hits on google, world acclamation from industry, academia, drug authorities for websites, blogs and educational contributio

Monday, 20 June 2016

Marion Rusch

Marion Rusch.

Marion Rusch

R&D New Solutions Manager (Chemistry) chez RELX Intellectual Properties SA



R&D New Solutions Manager (Chemistry)

RELX Intellectual Properties SA
 – Present (9 months)Neuchâtel- SWITZERLAND
Enhancement of current and future value of Reaxys and Reaxys Medicinal Chemistry

Postdoctoral fellow at NIBR

Novartis Institutes for BioMedical Research
 –  (3 years)Basel-SWITZERLAND
Development of chemical tools to study stem cell biology

Postdoctoral Fellow

MPI- Max Planck Institute of molecular physiology in Dortmund – GERMANY
 –  (1 year 1 month)Dortmund – GERMANY
Development and use of chemical tools to study protein depalmitoylation

PhD. in Chemistry and Biochemistry

Max Planck Institut für Molekular physiologie
 –  (4 years 1 month)MPI- Max Planck Institute of molecular physiology in Dortmund – GERMANY
Inhibitors synthesis with anticancer activity and determination of their biological targets by pull down experiments – Completed in September 2011 (grade: very good).
Work performed under the supervision of Prof. Herbert Waldmann and Dr. Christian Hedberg

Research work for M.Sc.

CNRS - Centre national de la recherche scientifique
 –  (7 months)National Centre for Scientific Research in Lyon – FRANCE
Laboratory for Organometallic Synthesis and BIOactive Molecules (SOMBIO),
Synthesis and characterization of heterocyclic compounds using palladium or iodine-organocatalysed reactions


 –  (7 months)Neuville-sur-Saône-FRANCE
Laboratory for the Improvement of Process engineering
Development of a new TLC-based detection and quantification method for impurities, control of production batchs and routine analyses

Research Internship

Bayer CropScience
 –  (7 months)Research centre of Lyon -FRANCE
Synthesis and characterization of new compound with fungicidal activity


5th Year of higher education at CPE Lyon & MSc level, University Claude Bernard Lyon I

MSc Level (pass mark: 14,8 /20, 4th place), Engineer degree CPE LYON

Specialised in organic chemistry and bioactive molecule chemistry

3rd and 4th Year of higher education at CPE Lyon (Chemistry, Physics and Electronics)

Specialised in organic chemistry and process engineering

CPE Lyon (Chemistry, Physics and Electronics)

Preparatory classes- two years full-time higher education in mathematics, Sciences and general studies, in preparation for selective admission to CPE Lyon.

Secondary school in FRANCE

Higher secondary leaving certificate (Baccalauréat) in mathematics, physics, chemistry with general studies and languages (English and German)
RELX Intellectual Properties


Increasing the speed and efficiency of chemistry research at any stage of the R&D cycle means getting to market faster. When researchers have easy access to lab-ready experimental data and procedures, accurate information to inform synthesize-or-purchase decisions, and relevant answers to a whole range of chemistry questions, the whole R&D process improves.

Reaxys and Reaxys Medicinal Chemistry are two powerful chemistry research solutions that provide that speed and efficiency. 

Reaxys covers every field of chemistry with a comprehensive and highly indexed database containing over 500 million published experimental facts about over 55 million organic, inorganic and organometallic compounds. From drug development to oil and gas research, Reaxys supports the full chemistry workflow with functions and data to cover every stage of the R&D process from idea to synthesis. 
Reaxys Medicinal Chemistry is the world’s largest and best-organized medicinal chemistry database, with normalized bioactivity data on 5.1 million unique substances and 9,200 druggable targets. It is designed to support researchers in making connections between compounds, targets and bioactivity, allowing rapid early-stage drug candidate assessment.

Reaxys and Reaxys Medicinal Chemistry are available as separate products or together as a fully integrated solution accessible through a single, streamlined user interface.
  • Use Reaxys and Reaxys Medicinal Chemistry together to maximize your research capabilities in early-stage drug discovery and drug candidate synthesis
  • If in-depth bioactivity data is not part of your research, use Reaxys alone and focus on chemical structures, properties, reactions and synthesis
  • If your researchers have a strict focused on bioactivity data, use Reaxys Medicinal Chemistry alone for its unique, comprehensive bioactivity database